En-Min Li Selected Research

ezrin

10/2019	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.
1/2019	Heat shock protein family B member 1 facilitates ezrin activation to control cell migration in esophageal squamous cell carcinoma.
1/2018	The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells.
12/2017	L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
1/2017	Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma.
1/2017	A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
1/2017	Ezrin Ser66 phosphorylation regulates invasion and metastasis of esophageal squamous cell carcinoma cells by mediating filopodia formation.
1/2015	12-O-Tetradecanoylphorbol-13-Acetate Induces Up-Regulated Transcription of Variant 1 but Not Variant 2 of VIL2 in Esophageal Squamous Cell Carcinoma Cells via ERK1/2/AP-1/Sp1 Signaling.
10/2011	Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
6/2009	Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

En-Min Li Research Topics

Disease

109	Neoplasms (Cancer) 07/2022 - 11/2002
85	Esophageal Squamous Cell Carcinoma 05/2022 - 03/2004
21	Carcinogenesis 12/2021 - 03/2004
20	Esophageal Neoplasms (Esophageal Cancer) 07/2022 - 01/2010
20	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2008
18	Carcinoma (Carcinomatosis) 07/2015 - 10/2002
14	Lymphatic Metastasis 01/2020 - 09/2008
7	Adenocarcinoma 11/2020 - 02/2008
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 06/2009
4	Stomach Neoplasms (Stomach Cancer) 01/2020 - 06/2011
3	Nasopharyngeal Carcinoma 01/2017 - 09/2014
2	Genomic Instability 03/2021 - 11/2020
2	Glioma (Gliomas) 07/2020 - 01/2015
2	Inflammation (Inflammations) 01/2020 - 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2020
1	Polyps 01/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020
1	Circulating Neoplastic Cells 01/2020

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 07/2022 - 10/2002
26	Biomarkers (Surrogate Marker)IBA 07/2022 - 04/2005
15	fascinIBA 01/2022 - 03/2004
12	Lipocalin-2IBA 10/2015 - 02/2003
11	Messenger RNA (mRNA)IBA 01/2020 - 12/2008
11	ezrinIBA 10/2019 - 03/2009
10	AutoantibodiesIBA 09/2019 - 01/2014
8	Biological ProductsIBA 01/2022 - 09/2014
8	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2011
7	AntigensIBA 01/2020 - 01/2014
7	Long Noncoding RNAIBA 01/2020 - 01/2018
6	Riboflavin (Vitamin B2)FDA LinkGeneric 08/2021 - 01/2017
6	EnzymesIBA 01/2020 - 01/2014
6	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2020 - 07/2012
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 09/2014
4	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 02/2016
4	GTP Phosphohydrolases (GTPases)IBA 12/2021 - 07/2007
4	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 01/2014
4	CateninsIBA 01/2017 - 04/2012
3	Lysine (L-Lysine)FDA Link 01/2022 - 01/2014
3	Protein Isoforms (Isoforms)IBA 08/2021 - 10/2014
3	ImmunosorbentsIBA 01/2020 - 01/2014
3	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2020 - 12/2017
3	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 03/2011
3	RNA (Ribonucleic Acid)IBA 01/2018 - 03/2003
3	conglobatinIBA 01/2018 - 03/2015
3	IntegrinsIBA 02/2016 - 06/2015
3	Cadherins (E-Cadherin)IBA 10/2015 - 10/2013
3	LipocalinsIBA 07/2015 - 03/2003
3	Histone DemethylasesIBA 03/2015 - 01/2013
3	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2010 - 11/2002
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2015
2	Serine (L-Serine)FDA Link 01/2022 - 01/2017
2	GuanosineIBA 12/2021 - 12/2020
2	XenobioticsIBA 03/2021 - 11/2020
2	ChromatinIBA 01/2021 - 01/2013
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 12/2020 - 10/2020
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2020 - 10/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2020 - 01/2019
2	MethyltransferasesIBA 01/2020 - 01/2016
2	Microfilament Proteins (Actin Binding Proteins)IBA 10/2019 - 01/2014
2	moesinIBA 01/2018 - 10/2011
2	Actins (F Actin)IBA 01/2018 - 01/2017
2	radixinIBA 01/2018 - 10/2011
2	Amino Acids FDA Link 01/2017 - 03/2015
2	AgarIBA 11/2016 - 04/2012
2	Oncogene Proteins (Oncogene Protein)IBA 02/2016 - 03/2003
2	Immunoglobulin A (IgA)IBA 08/2015 - 09/2014
2	MacrolidesIBA 06/2015 - 03/2015
2	Desmoglein 3IBA 06/2014 - 01/2014
2	beta CateninIBA 10/2013 - 07/2011
2	Cell Surface ReceptorsIBA 08/2011 - 07/2007
2	Epidermal Growth Factor (EGF)IBA 10/2010 - 11/2002
2	hydrogen sulfite (bisulfite)IBA 09/2009 - 12/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2009 - 04/2009
2	Nuclear Matrix-Associated ProteinsIBA 04/2005 - 10/2003
1	Caspase 3 (Caspase-3)IBA 07/2022
1	CalpainIBA 07/2022
1	Caspase 9IBA 07/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2022
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	nedaplatinIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 12/2021
1	Rho Guanine Nucleotide Exchange FactorsIBA 12/2021
1	PlatinumIBA 02/2021
1	DisulfidesIBA 01/2021
1	Insulin-Like Growth Factor Binding ProteinsIBA 11/2020
1	Pharmaceutical PreparationsIBA 08/2020
1	imperatorinIBA 08/2020
1	A-Form DNA (A-DNA)IBA 01/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Insulin-Like Growth Factor Binding Protein 1IBA 01/2020
1	Insulin-Like PeptidesIBA 01/2020

Therapy/Procedure

12	Therapeutics 05/2022 - 10/2010
5	Chemoradiotherapy 07/2022 - 08/2020
5	Drug Therapy (Chemotherapy) 07/2022 - 01/2014
3	Radiotherapy 05/2022 - 12/2020
2	Biological Therapy 08/2016 - 04/2007